MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202511112758 A) filed by Ms. Neha Gupta, Moradabad, Uttar Pradesh, on Nov. 17, 2025, for 'nanoengineered biopolymeric systems integrating synthetic and phytochemical therapeutics for controlled drug delivery system.'
Inventor(s) include Ms. Neha Gupta; Ms. Rachana Belwal; Ms. Neha Gupta; Dr. Garima Verma; Dr. Charu Khanna; Dr. Arun Kumar Maurya; Dr. Vikas Saxena; Dr. Kuldeep Shukla; Dr. Anjali Khare; Mr. Rajat Saxena; Mrs. Deeksha Pathak; and Dr. Abhishek Kumar.
The application for the patent was published on Jan. 9, under issue no. 02/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to nanoengineered biopolymeric systems that integrate both synthetic pharmaceutical agents and phytochemical therapeutics within a unified controlled drug delivery platform. The invention comprises biodegradable polymeric nanoparticles incorporating synthetic drugs and plant-derived bioactive compounds in a synergistic formulation. The system employs amphiphilic biopolymers such as polylactic-co-glycolic acid, chitosan, alginate, or cellulose derivatives as carrier matrices, modified through surface engineering to achieve targeted delivery and controlled release kinetics. The nanoparticles exhibit particle sizes ranging from 50 to 500 nanometers with high encapsulation efficiency exceeding 85 percent for both hydrophobic and hydrophilic therapeutic agents. The dual-loading architecture enables simultaneous delivery of complementary therapeutic modalities while minimizing systemic toxicity through sustained release mechanisms. The invention addresses limitations of conventional drug delivery by combining the precision of synthetic pharmaceuticals with the multitarget efficacy of phytochemicals, thereby enhancing therapeutic outcomes in oncology, inflammatory disorders, and chronic diseases requiring combination therapy approaches."
Disclaimer: Curated by HT Syndication.
